Hydroxychloroquine Delays Disability for Least Treatable Form of Multiple Sclerosis

Hydroxychloroquine shows promise for reducing some of the debilitating systems associated with primary progressive multiple sclerosis, a new study reports. A University of Calgary study…

View More Hydroxychloroquine Delays Disability for Least Treatable Form of Multiple Sclerosis

Disrupted connectivity in Parkinson’s disease (PD) with the probable Rapid eye movement behavior disorder ( RBD)

Rapid eye movement sleep behavior disorder ( RBD) is a kind of sleep disorder in which a person experiences some physical movements and unpleasant dreams…

View More Disrupted connectivity in Parkinson’s disease (PD) with the probable Rapid eye movement behavior disorder ( RBD)

Twins Study Indicates Environmental Factors Significant in Alzheimer’s Pathology

Genes only play a moderate role in the accumulation of amyloid-beta in the brain. The question of genetic vs environmental influences plays a major role…

View More Twins Study Indicates Environmental Factors Significant in Alzheimer’s Pathology

Cabozantinib Shows Promise for Renal Cell Carcinoma With Brain Metastases

Cabozantinib yields promising intracranial activity with an acceptable safety profile for patients who developed brain metastases from renal cell carcinoma (RCC), according to study results…

View More Cabozantinib Shows Promise for Renal Cell Carcinoma With Brain Metastases

Exercise Therapy Has Positive Effect on Multiple Sclerosis-Related Fatigue

Exercise is an effective therapeutic strategy for fatigue in patients with multiple sclerosis (MS), and combined exercise is the most effective modality for physical and…

View More Exercise Therapy Has Positive Effect on Multiple Sclerosis-Related Fatigue